C-19

Pharmaceutical companies must pay close attention to the customer experience to truly drive successful product launches.

Gain insights into buying behavior and improve customer experience by digital customer journey mapping. Implement digital touchpoints across all channels

Get real time updates on the Genome Sequencing Industry with the latest reports, critical insights and stats from official sources. Understand the impact of the crisis on your market.

Help prevent disease in your communities with population health solutions. Learn about our affordable, turnkey solution using the power of genomics.

Helix partnered with Renown Institute for Health Innovation to carry out one of the world's fastest growing population genomics projects, the Healthy Nevada Project. Learn about early findings from this ground breaking population genomics study.

Helix is a population genomics company with a mission to empower every person to improve their life through DNA.

Helix is a population genomics company with a mission to empower every person to improve their life through DNA.

Helix is a population genomics company with a mission to empower every person to improve their life through DNA.

Helix is a population genomics company with a mission to empower every person to improve their life through DNA.

As a global company committed to supporting the fight against COVID-19, we are humbled to see our technology powering scientists around the world.

Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics.

SGS is the world's leading inspection, verification, testing and certification company. We are recognized as the global benchmark for quality and integrity.

Read this article on Questia.

Serologic tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now widely available. IDSA has developed recommendations related to the use of SARS-CoV-2 serologic testing in clinical practice and public health.

Thermo Fisher Scientific offers a comprehensive portfolio of laboratory products and remote service options for your SARS-CoV-2 coronavirus research needs.

Discover our epidemiological research surveillance solutions using next-generation sequencing and gene synthesis for your SARS-CoV-2 investigation.

From viral research and epidemiological studies to potential vaccine development, advance your SARS-CoV-2 research with our solutions.

Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space

The purpose of this paper is to formulate a professional and scientific view on the social, ethical, and legal issues that impact on data storage and DNA banking practices for biomedical research in Europe. Many aspects have been considered, such as the requirements for data storage and DNA banking in the public and private sectors in Europe and the issues relating to DNA banking, that is to say the consent requirements for the banking and further uses of DNA samples, their control and ownership, and the return of benefit derived from DNA exploitation to the community. The methods comprise ...

Commercialized biobanking for genetic testing shows potential as resource for personalized medicine research but also raises concerns over ethical issues.

To build and scale a successful SaaS company, make thoughtful, data-driven decisions by tracking and improving the most important SaaS metrics and KPIs.

Did you know that the healthcare industry brings in $1.68 trillion in revenue annually? As a profitable industry, many companies want to break into this market segment through innovative new solutions. However, ensuring the business is performing effectively and profitably is imperative to its long-term success. If you offer Software as a Service (SaaS) applications ...

This is an effort to compile a repository of the clinical characteristics of COVID-19 tested patients.